James E Flynn Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for James E Flynn.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of James E Flynn. James E Flynn is 10% Owner in CAS MEDICAL SYSTEMS INC ($CAMY.OB) and 10% Owner in AxoGen, Inc. ($LECT) and 10% Owner in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in STREAMLINE HEALTH SOLUTIONS INC. ($LANV) and 10% Owner in ANTARES PHARMA, INC. ($ATRS) and 10% Owner in VIA Pharmaceuticals, Inc. ($CAQ) and 10% Owner in DUSA PHARMACEUTICALS INC ($DUSA) and 10% Owner in HI TECH PHARMACAL CO INC ($HITK) and 10% Owner in AVADEL PHARMACEUTICALS PLC ($AVDL) and 10% Owner in INSPIRE PHARMACEUTICALS INC ($ISPH) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in ARENA PHARMACEUTICALS INC ($ARNA) and 10% Owner in ISTA PHARMACEUTICALS INC ($ISTA) and 10% Owner in MEDICINES CO /DE ($MDCO) and 10% Owner in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and Director in Talon Therapeutics, Inc. ($EMLR) and 10% Owner in LUMOS PHARMA, INC. ($NLNK) and 10% Owner in NITROMED INC ($NTMD) and 10% Owner in XENOPORT INC ($XNPT) and 10% Owner in EMAGEON INC ($EMAG) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in NeuroMetrix, Inc. ($NURO) and 10% Owner in NxStage Medical, Inc. ($NXTM) and 10% Owner in aTYR PHARMA INC ($LIFE) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and Director in PROTEON THERAPEUTICS INC ($PRTO) and 10% Owner in eHealth, Inc. ($EHTH) and 10% Owner in ZAFGEN, INC. ($ZFGN) and 10% Owner in NeurogesX Inc ($NGSX) and 10% Owner in Invuity, Inc. ($IVTY) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and 10% Owner in TriVascular Technologies, Inc. ($TRIV) and 10% Owner in Auspex Pharmaceuticals, Inc. ($ASPX) and 10% Owner in Neos Therapeutics, Inc. ($NEOS) and 10% Owner in Schrodinger, Inc. ($SDGR) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in Acutus Medical, Inc. ($AFIB) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Mallinckrodt plc ($MNK) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Adverum Biotechnologies, Inc. ($AAVL) and 10% Owner in REGENXBIO Inc. ($RGNX) and 10% Owner in Recro Pharma, Inc. ($REPH) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and Director in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in ShockWave Medical, Inc. ($SWAV) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Editas Medicine, Inc. ($EDIT) and Director in AveXis, Inc. ($AVXS) and 10% Owner in ARVINAS INC. ($ARVN) and 10% Owner in Homology Medicines, Inc. ($FIXX) and Director in Homology Medicines, Inc. ($FIXX) and Director in Oncorus, Inc. ($ONCR) and 10% Owner in Revolution Medicines, Inc. ($RVMD) and 10% Owner in Black Diamond Therapeutics, Inc. ($BDTX) and 10% Owner in Frequency Therapeutics, Inc. ($FREQ) and Director in DFB Healthcare Acquisitions Corp. ($DFBH) and 10% Owner in Generation Bio Co. ($GBIO) and 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Cabaletta Bio, Inc. ($CABA) and 10% Owner in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and Director in DFP HEALTHCARE ACQUISITIONS CORP. ($DFPH) and Director in Deerfield Healthcare Technology Acquisitions Corp. ($DFHT) and 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).

Latest Insider Trading Transactions of James E Flynn

Sentiment: All, ACRS, AFIB, DFBH, ADVM, ALIM, ALPN, ANNX, ATRS, ARNA, ARVN, LIFE, BOLD, ASPX, AVDL, AVXS, LECT, BDTX, CABA, CAMY.OB, CBIO, CNST, CYCC, CTMX, DFHTW, DFPHU, DRNA, DUSA, DVAX, EWTX, EDIT, EHTH, EMAG, FCSC, FREQ, GBIO, HITK, FIXX, ISPH, IVTY, ISTA, KNSA, LRMR, LOXO, NLNK, MNK, MDCO, MIRM, NEOS, NGSX, NURO, NTMD, NKTX, NXTM, ONCR, PRX, TARA, REPH, RGNX, RVMD, RYTM, RIGL, SDGR, SWAV, STDY, LANV, SYRS, EMLR, TERN, TWTI, TRIV, VNDA, CAQ, HOWL, XNPT, XERS

Page:   < prev 1 2 3 4 5 6 ... 10 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 07 2019XERSXERIS PHARMACEUTIC ...Flynn James E10% OwnerSellS15.004006,000873,120873.5 K to 873.1 K (-0.05 %)
Feb 07 2019XERSXERIS PHARMACEUTIC ...Flynn James E10% OwnerSellS15.074,99875,308873,520878.5 K to 873.5 K (-0.57 %)
Jan 30 2019XERSXERIS PHARMACEUTIC ...Flynn James E10% OwnerSellS15.146,21094,028878,518884.7 K to 878.5 K (-0.70 %)
Jan 30 2019XERSXERIS PHARMACEUTIC ...Flynn James E10% OwnerSellS15.0082812,420884,728885.6 K to 884.7 K (-0.09 %)
Jan 25 2019XERSXERIS PHARMACEUTIC ...Flynn James E10% OwnerSellS15.0876,8201,158,254885,556962.4 K to 885.6 K (-7.98 %)
Jan 25 2019XERSXERIS PHARMACEUTIC ...Flynn James E10% OwnerSellS15.035,42581,563962,376967.8 K to 962.4 K (-0.56 %)
Jan 25 2019XERSXERIS PHARMACEUTIC ...Flynn James E10% OwnerSellS16.3532,199526,376967,8011000 K to 967.8 K (-3.22 %)
Jan 18 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.93171
Jan 18 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.97171
Jan 18 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ7.00171
Jan 02 2019ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ7.00171
Dec 27 2018ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.89171
Dec 27 2018ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.86171
Dec 27 2018ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.92171
Dec 27 2018ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.89171
Dec 27 2018ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.86171
Dec 27 2018ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.92171
Dec 21 2018ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.95171
Dec 21 2018ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.84171
Dec 21 2018ACRSAclaris Therapeuti ...Flynn James E10% OwnerOption ExerciseJ6.91171
Oct 01 2018ARVNARVINAS INC.Flynn James E10% OwnerOption ExerciseC0.00998,00400
Oct 01 2018ARVNARVINAS INC.Flynn James E10% OwnerOption ExerciseC0.00998,00400
Oct 01 2018ARVNARVINAS INC.Flynn James E10% OwnerOption ExerciseC0.00998,00400
Oct 01 2018ARVNARVINAS INC.Flynn James E10% OwnerBuyP16.00104,1661,666,656411,244307.1 K to 411.2 K (+33.92 %)
Oct 01 2018ARVNARVINAS INC.Flynn James E10% OwnerBuyP16.00104,1671,666,672411,245307.1 K to 411.2 K (+33.92 %)
Oct 01 2018ARVNARVINAS INC.Flynn James E10% OwnerBuyP16.00104,1671,666,672411,245307.1 K to 411.2 K (+33.92 %)
Oct 01 2018ARVNARVINAS INC.Flynn James E10% OwnerBuyC0.00307,0780307,0780 to 307.1 K
Oct 01 2018ARVNARVINAS INC.Flynn James E10% OwnerBuyC0.00307,0780307,0780 to 307.1 K
Oct 01 2018ARVNARVINAS INC.Flynn James E10% OwnerBuyC0.00307,0780307,0780 to 307.1 K
Jul 23 2018CNSTCONSTELLATION PHAR ...Flynn James E10% OwnerOption ExerciseC0.007,000,00000
Jul 23 2018CNSTCONSTELLATION PHAR ...Flynn James E10% OwnerBuyP15.00200,0003,000,000835,843635.8 K to 835.8 K (+31.45 %)
Jul 23 2018CNSTCONSTELLATION PHAR ...Flynn James E10% OwnerBuyC0.00635,8430635,8430 to 635.8 K
Jun 27 2018XERSXERIS PHARMACEUTIC ...Flynn James E10% OwnerOption ExerciseC0.001,557,29200
Jun 27 2018XERSXERIS PHARMACEUTIC ...Flynn James E10% OwnerOption ExerciseC0.001,557,29200
Jun 27 2018XERSXERIS PHARMACEUTIC ...Flynn James E10% OwnerBuyP15.00624,3339,364,9951,498,666874.3 K to 1.5 M (+71.41 %)
Jun 27 2018XERSXERIS PHARMACEUTIC ...Flynn James E10% OwnerBuyP15.00125,6671,885,0051,000,000874.3 K to 1000 K (+14.37 %)
Jun 27 2018XERSXERIS PHARMACEUTIC ...Flynn James E10% OwnerBuyC0.00874,3330874,3330 to 874.3 K
Jun 27 2018XERSXERIS PHARMACEUTIC ...Flynn James E10% OwnerBuyC0.00874,3330874,3330 to 874.3 K
Jun 25 2018AVDLAVADEL PHARMACEUTI ...Flynn James E10% OwnerSellS5.99114,034683,315952,2651.1 M to 952.3 K (-10.69 %)
Jun 12 2018PRTOPROTEON THERAPEUTI ...Flynn James EDirectorOption ExerciseA2.5012,70031,75012,700
May 31 2018KNSAKiniksa Pharmaceut ...Flynn James E10% OwnerOption ExerciseC0.00383,53800
May 31 2018KNSAKiniksa Pharmaceut ...Flynn James E10% OwnerBuyP19.24235,0194,520,943843,352608.3 K to 843.4 K (+38.63 %)
May 31 2018KNSAKiniksa Pharmaceut ...Flynn James E10% OwnerBuyP20.9125,000522,748608,333583.3 K to 608.3 K (+4.29 %)
May 31 2018KNSAKiniksa Pharmaceut ...Flynn James E10% OwnerBuyP19.81250,0004,953,150583,333333.3 K to 583.3 K (+75.00 %)
May 31 2018KNSAKiniksa Pharmaceut ...Flynn James E10% OwnerBuyP18.00333,3335,999,994333,3330 to 333.3 K
May 31 2018KNSAKiniksa Pharmaceut ...Flynn James E10% OwnerBuyC0.00383,5380383,5380 to 383.5 K
May 10 2018MNKMallinckrodt plcFlynn James E10% OwnerSellS13.74202,0062,775,5628,308,4558.5 M to 8.3 M (-2.37 %)
May 10 2018MNKMallinckrodt plcFlynn James E10% OwnerSellS12.75110,9221,414,2568,510,4618.6 M to 8.5 M (-1.29 %)
Apr 04 2018FIXXHomology Medicines ...Flynn James EDirectorOption ExerciseC0.006,944,44400
Apr 04 2018FIXXHomology Medicines ...Flynn James EDirectorOption ExerciseC0.006,944,44500
Apr 04 2018FIXXHomology Medicines ...Flynn James EDirectorOption ExerciseC0.003,521,12600
Apr 04 2018FIXXHomology Medicines ...Flynn James EDirectorOption ExerciseC0.003,521,12600
Apr 04 2018FIXXHomology Medicines ...Flynn James EDirectorBuyP16.00625,00010,000,000625,0000 to 625 K
Apr 04 2018FIXXHomology Medicines ...Flynn James EDirectorBuyP16.00625,00010,000,0002,613,5172 M to 2.6 M (+31.43 %)
Apr 04 2018FIXXHomology Medicines ...Flynn James EDirectorBuyC0.001,319,48301,988,517669 K to 2 M (+197.22 %)
Apr 04 2018FIXXHomology Medicines ...Flynn James EDirectorBuyC0.001,319,48401,988,518669 K to 2 M (+197.22 %)
Apr 04 2018FIXXHomology Medicines ...Flynn James EDirectorBuyC0.00669,0340669,0340 to 669 K
Apr 04 2018FIXXHomology Medicines ...Flynn James EDirectorBuyC0.00669,0340669,0340 to 669 K
Apr 04 2018DFBHDFB Healthcare Acq ...Flynn James EDirectorSellJ0.003,913026,08730 K to 26.1 K (-13.04 %)
Apr 04 2018DFBHDFB Healthcare Acq ...Flynn James EDirectorSellJ0.00921,84806,045,6527 M to 6 M (-13.23 %)
Mar 29 2018FIXXHomology Medicines ...Flynn James EDirectorOption ExerciseA16.0031,160498,56031,160
Mar 08 2018CBIOCATALYST BIOSCIENC ...Flynn James E10% OwnerSellS29.038,123235,8111,113,2221.1 M to 1.1 M (-0.72 %)
Mar 08 2018CBIOCATALYST BIOSCIENC ...Flynn James E10% OwnerSellS30.001,19435,8201,121,3451.1 M to 1.1 M (-0.11 %)
Mar 08 2018CBIOCATALYST BIOSCIENC ...Flynn James E10% OwnerSellS30.0010,000300,0001,122,5391.1 M to 1.1 M (-0.88 %)
Mar 08 2018CBIOCATALYST BIOSCIENC ...Flynn James E10% OwnerSellS31.1839,3001,225,3741,132,5391.2 M to 1.1 M (-3.35 %)
Mar 08 2018CBIOCATALYST BIOSCIENC ...Flynn James E10% OwnerSellS29.9413,161394,0401,171,8391.2 M to 1.2 M (-1.11 %)
Feb 23 2018DFBHDFB Healthcare Acq ...Flynn James EDirectorOption ExerciseP11.504,333,33349,833,3304,333,333
Feb 23 2018DFBHDFB Healthcare Acq ...Flynn James EDirectorOption ExerciseP11.50833,3339,583,330833,333
Feb 23 2018DFBHDFB Healthcare Acq ...Flynn James EDirectorBuyP0.002,500,00002,500,0000 to 2.5 M
Dec 04 2017PRTOPROTEON THERAPEUTI ...Flynn James EDirectorSellS1.75110,557193,4750110.6 K to 0 (-100.00 %)
Dec 04 2017PRTOPROTEON THERAPEUTI ...Flynn James EDirectorBuyP1.75110,557193,475197,42486.9 K to 197.4 K (+127.27 %)
Oct 10 2017RYTMRHYTHM PHARMACEUTI ...Flynn James E10% OwnerOption ExerciseC0.002,668,51800
Oct 10 2017RYTMRHYTHM PHARMACEUTI ...Flynn James E10% OwnerOption ExerciseC0.002,668,51800
Oct 10 2017RYTMRHYTHM PHARMACEUTI ...Flynn James E10% OwnerBuyP17.00177,5003,017,500468,505291 K to 468.5 K (+61.00 %)
Oct 10 2017RYTMRHYTHM PHARMACEUTI ...Flynn James E10% OwnerBuyP17.00177,5003,017,500468,505291 K to 468.5 K (+61.00 %)
Oct 10 2017RYTMRHYTHM PHARMACEUTI ...Flynn James E10% OwnerBuyC0.00291,0050291,0050 to 291 K
Oct 10 2017RYTMRHYTHM PHARMACEUTI ...Flynn James E10% OwnerBuyC0.00291,0050291,0050 to 291 K
Aug 04 2017PRTOPROTEON THERAPEUTI ...Flynn James EDirectorOption ExerciseA1.3013,33317,33313,333
Jun 14 2017REPHRecro Pharma, Inc.Flynn James E10% OwnerSellS6.2568,000425,0001,176,6851.2 M to 1.2 M (-5.46 %)
Jun 14 2017REPHRecro Pharma, Inc.Flynn James E10% OwnerSellS6.5932,447213,8261,244,6851.3 M to 1.2 M (-2.54 %)
Jun 14 2017REPHRecro Pharma, Inc.Flynn James E10% OwnerSellS6.7410,00067,4001,277,1321.3 M to 1.3 M (-0.78 %)
Jun 09 2017REPHRecro Pharma, Inc.Flynn James E10% OwnerSellS6.9917,245120,5431,287,1321.3 M to 1.3 M (-1.32 %)
Jun 09 2017REPHRecro Pharma, Inc.Flynn James E10% OwnerSellS7.0945,623323,4671,304,3771.4 M to 1.3 M (-3.38 %)
Apr 27 2017EHTHeHealth, Inc.Flynn James E10% OwnerSellS11.7171,837841,211877,606949.4 K to 877.6 K (-7.57 %)
Apr 27 2017EHTHeHealth, Inc.Flynn James E10% OwnerSellS11.7158,067679,965709,386767.5 K to 709.4 K (-7.57 %)
Apr 27 2017EHTHeHealth, Inc.Flynn James E10% OwnerSellS11.71183,8052,152,357244,562428.4 K to 244.6 K (-42.91 %)
Apr 27 2017EHTHeHealth, Inc.Flynn James E10% OwnerSellS11.5225,932298,737949,443975.4 K to 949.4 K (-2.66 %)
Apr 27 2017EHTHeHealth, Inc.Flynn James E10% OwnerSellS11.5220,962241,482767,453788.4 K to 767.5 K (-2.66 %)
Apr 27 2017EHTHeHealth, Inc.Flynn James E10% OwnerSellS11.5266,351764,364428,367494.7 K to 428.4 K (-13.41 %)
Apr 17 2017EHTHeHealth, Inc.Flynn James E10% OwnerSellS11.0034,349377,839975,3751 M to 975.4 K (-3.40 %)
Apr 17 2017EHTHeHealth, Inc.Flynn James E10% OwnerSellS11.0027,765305,415788,415816.2 K to 788.4 K (-3.40 %)
Apr 17 2017EHTHeHealth, Inc.Flynn James E10% OwnerSellS11.0087,886966,746494,718582.6 K to 494.7 K (-15.09 %)
Apr 11 2017EHTHeHealth, Inc.Flynn James E10% OwnerSellS11.017,65884,3341,009,7241 M to 1 M (-0.75 %)
Apr 11 2017EHTHeHealth, Inc.Flynn James E10% OwnerSellS11.016,18968,156816,180822.4 K to 816.2 K (-0.75 %)
Apr 11 2017EHTHeHealth, Inc.Flynn James E10% OwnerSellS11.0119,593215,768582,604602.2 K to 582.6 K (-3.25 %)
Apr 11 2017EHTHeHealth, Inc.Flynn James E10% OwnerSellS11.0418,264201,5891,017,3821 M to 1 M (-1.76 %)
Apr 11 2017EHTHeHealth, Inc.Flynn James E10% OwnerSellS11.0414,763162,947822,369837.1 K to 822.4 K (-1.76 %)
Apr 11 2017EHTHeHealth, Inc.Flynn James E10% OwnerSellS11.0446,730515,782602,197648.9 K to 602.2 K (-7.20 %)
Apr 11 2017EHTHeHealth, Inc.Flynn James E10% OwnerSellS11.7227,228319,0111,035,6461.1 M to 1 M (-2.56 %)
Apr 11 2017EHTHeHealth, Inc.Flynn James E10% OwnerSellS11.7222,009257,864837,132859.1 K to 837.1 K (-2.56 %)
Apr 11 2017EHTHeHealth, Inc.Flynn James E10% OwnerSellS11.7269,667816,239648,927718.6 K to 648.9 K (-9.69 %)
Jan 26 2017CAMY.OBCAS MEDICAL SYSTEM ...Flynn James E10% OwnerSellS1.46517,450752,9412,358,6362.9 M to 2.4 M (-17.99 %)
Jan 26 2017CAMY.OBCAS MEDICAL SYSTEM ...Flynn James E10% OwnerSellS1.5071,468107,2232,876,0862.9 M to 2.9 M (-2.42 %)
Jan 26 2017CAMY.OBCAS MEDICAL SYSTEM ...Flynn James E10% OwnerSellS1.5047,32071,0652,947,5543 M to 2.9 M (-1.58 %)
Jan 23 2017CAMY.OBCAS MEDICAL SYSTEM ...Flynn James E10% OwnerSellS1.4786,691127,0022,994,8743.1 M to 3 M (-2.81 %)
Jan 23 2017CAMY.OBCAS MEDICAL SYSTEM ...Flynn James E10% OwnerSellS1.5346,52271,2673,081,5653.1 M to 3.1 M (-1.49 %)
Jan 23 2017CAMY.OBCAS MEDICAL SYSTEM ...Flynn James E10% OwnerSellS1.6071,913115,0823,128,0873.2 M to 3.1 M (-2.25 %)
Dec 14 2016IVTYInvuity, Inc.Flynn James E10% OwnerSellS6.0145,568273,6771,690,4981.7 M to 1.7 M (-2.62 %)
Dec 14 2016IVTYInvuity, Inc.Flynn James E10% OwnerSellS6.1371,173436,1481,736,0661.8 M to 1.7 M (-3.94 %)
Dec 14 2016IVTYInvuity, Inc.Flynn James E10% OwnerSellS6.4568,055439,0841,807,2391.9 M to 1.8 M (-3.63 %)
Sep 26 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS16.71157,6072,633,140693,171850.8 K to 693.2 K (-18.53 %)
Sep 26 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS16.71348,2585,818,3462,035,6972.4 M to 2 M (-14.61 %)
Sep 26 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS16.71273,6324,571,5701,599,4761.9 M to 1.6 M (-14.61 %)
Sep 26 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS16.2468,9401,119,517850,778919.7 K to 850.8 K (-7.50 %)
Sep 26 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS16.24152,3342,473,7522,383,9552.5 M to 2.4 M (-6.01 %)
Sep 26 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS16.24119,6901,943,6461,873,1082 M to 1.9 M (-6.01 %)
Sep 19 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS15.5837,044577,146919,718956.8 K to 919.7 K (-3.87 %)
Sep 19 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS15.534,91076,2422,536,2892.5 M to 2.5 M (-0.19 %)
Sep 19 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS15.533,85759,8911,992,7982 M to 2 M (-0.19 %)
Sep 19 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS15.6287,8581,372,254956,7621 M to 956.8 K (-8.41 %)
Sep 19 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS15.62119,0081,858,7862,541,1992.7 M to 2.5 M (-4.47 %)
Sep 19 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS15.6293,5061,460,4701,996,6552.1 M to 2 M (-4.47 %)
Sep 19 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS15.7658,997929,4981,044,6201.1 M to 1 M (-5.35 %)
Sep 19 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS15.7679,9151,259,0612,660,2072.7 M to 2.7 M (-2.92 %)
Sep 19 2016VNDAVanda Pharmaceutic ...Flynn James E10% OwnerSellS15.7662,791989,2722,090,1612.2 M to 2.1 M (-2.92 %)
Sep 14 2016NVLSNivalis Therapeuti ...Flynn James EDirectorOption ExerciseA7.7712,30095,57112,300
Aug 01 2016ZFGNZAFGEN, INC.Flynn James E10% OwnerSellS3.31901,4302,985,3561,151,8022.1 M to 1.2 M (-43.90 %)
Aug 01 2016ZFGNZAFGEN, INC.Flynn James E10% OwnerSellS3.31246,439816,157314,889561.3 K to 314.9 K (-43.90 %)
Aug 01 2016ZFGNZAFGEN, INC.Flynn James E10% OwnerSellS3.31193,630641,264247,413441 K to 247.4 K (-43.90 %)
Jul 25 2016BOLDAudentes Therapeut ...Flynn James E10% OwnerOption ExerciseC0.0099,83000
Jul 25 2016BOLDAudentes Therapeut ...Flynn James E10% OwnerOption ExerciseC0.0099,83000
Jul 25 2016BOLDAudentes Therapeut ...Flynn James E10% OwnerOption ExerciseC0.00267,99800
Jul 25 2016BOLDAudentes Therapeut ...Flynn James E10% OwnerOption ExerciseC0.00535,99600
Jul 25 2016BOLDAudentes Therapeut ...Flynn James E10% OwnerBuyP15.00146,5962,198,940514,424367.8 K to 514.4 K (+39.85 %)
Jul 25 2016BOLDAudentes Therapeut ...Flynn James E10% OwnerBuyP15.00253,4043,801,060889,230635.8 K to 889.2 K (+39.85 %)
Jul 25 2016BOLDAudentes Therapeut ...Flynn James E10% OwnerBuyC0.0099,8300367,828268 K to 367.8 K (+37.25 %)
Jul 25 2016BOLDAudentes Therapeut ...Flynn James E10% OwnerBuyC0.0099,8300635,826536 K to 635.8 K (+18.63 %)
Jul 25 2016BOLDAudentes Therapeut ...Flynn James E10% OwnerBuyC0.00267,9980267,9980 to 268 K
Jul 25 2016BOLDAudentes Therapeut ...Flynn James E10% OwnerBuyC0.00535,9960535,9960 to 536 K
Jul 21 2016LECTAxoGen, Inc.Flynn James E10% OwnerSellS6.70102,136684,3113,000,0003.1 M to 3 M (-3.29 %)
Jul 18 2016LECTAxoGen, Inc.Flynn James E10% OwnerSellS6.8741,425284,5903,102,1363.1 M to 3.1 M (-1.32 %)
Jul 18 2016LECTAxoGen, Inc.Flynn James E10% OwnerSellS7.3231,788232,6883,143,5613.2 M to 3.1 M (-1.00 %)
Jul 18 2016LECTAxoGen, Inc.Flynn James E10% OwnerSellS7.70206,0901,586,8933,175,3493.4 M to 3.2 M (-6.09 %)
Jul 06 2016SYRSSyros Pharmaceutic ...Flynn James E10% OwnerOption ExerciseC0.00508,56600
Jul 06 2016SYRSSyros Pharmaceutic ...Flynn James E10% OwnerOption ExerciseC0.00508,56600
Jul 06 2016SYRSSyros Pharmaceutic ...Flynn James E10% OwnerOption ExerciseC0.001,186,65400
Jul 06 2016SYRSSyros Pharmaceutic ...Flynn James E10% OwnerOption ExerciseC0.001,186,65400
Jul 06 2016SYRSSyros Pharmaceutic ...Flynn James E10% OwnerBuyP12.50120,0001,500,000628,566508.6 K to 628.6 K (+23.60 %)
Jul 06 2016SYRSSyros Pharmaceutic ...Flynn James E10% OwnerBuyP12.50120,0001,500,000628,566508.6 K to 628.6 K (+23.60 %)
Jul 06 2016SYRSSyros Pharmaceutic ...Flynn James E10% OwnerBuyP12.50280,0003,500,0001,466,6541.2 M to 1.5 M (+23.60 %)

Page:   < prev 1 2 3 4 5 6 ... 10 next >

Contact us | Follow us on Twitter